Heron Therapeutics
HRTX
$2.50
Share price
1.84%
Change (1 day)
4.39%
Change (1 year)
Categories
Heron Therapeutics (HRTX) - Total debt
Total debt on the balance sheet as of December 2023 : $0.17 B
According to Heron Therapeutics's latest financial reports the company's total debt is $0.17 B. A company’s total debt is the sum of all current and non-current debts.
Heron Therapeutics - Total debt on balance sheet (from 2011 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | 14.07% |
| 2022-12-31 | $0.15 B | -1.27% |
| 2021-12-31 | $0.15 B | 548.06% |
| 2020-12-31 | $24.61 M | 24.35% |
| 2019-12-31 | $19.79 M | 332.71% |
| 2018-12-31 | $4.57 M | -84.05% |
| 2017-12-31 | $28.68 M | -45.79% |
| 2016-12-31 | $52.91 M | 2281.23% |
| 2015-12-31 | $2.22 M | 39.05% |
| 2014-12-31 | $1.59 M | 55.9% |
| 2013-12-31 | $1.02 M | 108.33% |
| 2012-12-31 | $0.49 M | 377.67% |
| 2011-12-31 | $0.1 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $33.87 M | -81.14% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $0.58 B | 226.25% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $6.16 M | -96.57% | 🇺🇸 USA |
 Alkermes ALKS | $0.37 B | 107.20% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.11 B | -34.43% | 🇺🇸 USA |